- LISA FISHER
The Division of Genetics and Metabolism conducts a journal club on the second Wednesday of every month. Every session includes the presentation of a recent article from a peer reviewed journal which is sent to participants the preceding week. Presentation is followed by Q/A and group discussion. There is a different emphasis topic for each week with the topic areas rotating through the ACMGG competencies.
We plan to reach developmental pediatricians, clinical geneticists, genetic counselors, registered dieticians, medical assistants, advanced practice nurses, biochemical geneticists/fellows, molecular geneticists/fellows and cytogeneticists/fellows. Learners from each of these professional areas are also expected participants.
|Catherine Reiser, MS, CGC, Chair||David Wargowski, MD||Lisa Fisher, BA, Coordinator|
|In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.|
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education Units
The University of Wisconsin–Madison, as a member of the University Continuing Education Association (UCEA), authorizes this program for .01 continuing education units (CEUs) or 1 hour.
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison ICEP, that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s).
Detailed disclosures will be available prior to the start of the activity.
After participation in this regularly scheduled series, participants will be able to:
- Describe the scientific evidence influencing recent advances in medical genetics and related disciplines.
- Incorporate new diagnostic techniques and team-based management practices into overall patient care.